breathlessness Matthew Maddocks PhD Lecturer in Health Services - - PowerPoint PPT Presentation

breathlessness
SMART_READER_LITE
LIVE PREVIEW

breathlessness Matthew Maddocks PhD Lecturer in Health Services - - PowerPoint PPT Presentation

WHO Collaborating Centre for Palliative Care and Older People Exercise in the management of breathlessness Matthew Maddocks PhD Lecturer in Health Services Research NIHR Clinical Trials Fellow Background Breathlessness is common in


slide-1
SLIDE 1

WHO Collaborating Centre for Palliative Care and Older People

Exercise in the management of breathlessness

Matthew Maddocks PhD

Lecturer in Health Services Research NIHR Clinical Trials Fellow

slide-2
SLIDE 2

Background

  • Breathlessness is common in advanced disease

– 90% chronic lung disease – >50% cancer or heart failure – renal / liver failure, neurological conditions, HIV/AIDS.

  • It causes considerable distress and disability.
  • It results in unplanned hospital attendances.
  • Many perceive it as a challenge to treat (confidence,

structured approach, knowledge of treatments etc).

Maddocks et al. J Palliat Med 2015.

slide-3
SLIDE 3

Breathlessness is (a bit) like pain…

Parshall et al. AJRCCM 2012;185:435-52.

Domain Description Sensory-perceptive what does your breathing feel like and how bad is it? Affective distress how distressing or unpleasant is your breathing? Symptom impact or burden how does your breathing affect your function?

slide-4
SLIDE 4

The deconditioning spiral

  • Treatment goal: break or slow down the spiral
  • Requires education / reassurance around

normal exertional response and recovery

Donaldson et al. Int J COPD 2012;7:523-535. Maddocks & Wilcock. Lung Cancer 2012;76:128-9.

slide-5
SLIDE 5

Detrimental effect of bed rest on muscle

Kortbein JAMA 2007

Changes are about 10-fold compared to the typical response in a young adult

slide-6
SLIDE 6

Jolley & Moxham Eur Resp Rev 2009;818:66-79.

slide-7
SLIDE 7

Pulmonary rehabilitation

slide-8
SLIDE 8

Jolley & Moxham Eur Resp Rev 2009;818:66-79.

slide-9
SLIDE 9

Current evidence for PR

  • Overwhelming evidence supports exercise in the

context of pulmonary rehabilitation (PR)

  • CRQ dyspnoea scale

– ↑ 0.79 (CI 0.56−1.03), n=1283

  • SGRQ total score

– ↓ 6.89 (CI 9.26−4.52), n=1146

  • Exercise performance

– shuttle walk ↑ 39.8 m (CI 22.4−57.2), n=694 – 6 min walk ↑ 44.0 m (CI 32.6−55.2), n=1879

McCarthy et al. Cochrane Database Syst Rev. 2015;2:CD003793.

slide-10
SLIDE 10

CRQ dyspnoea domain (n=1286)

slide-11
SLIDE 11

CRQ Mastery (n=1212)

slide-12
SLIDE 12

PR and breathlessness

  • Rehabilitation compared to usual care (n=41)

Wadell et al. COPD 2013;10:425-35

Domain Assessments Sensory-perceptive Exertional breathlessness intensity ratings and quality descriptors Affective distress Intensity of breathing-related anxiety during exercise; COPD / walking self-efficacy Symptom impact or burden MRC dyspnoea scale; Transition Dyspnoea Index; CRQ dyspnoea scale; SRGQ activity scale; walking / cycling exercise performance

slide-13
SLIDE 13

Wadell et al. COPD 2013;10:425-35

PR and breathlessness

slide-14
SLIDE 14

Upper limb exercise

slide-15
SLIDE 15

Jolley & Moxham Eur Resp Rev 2009;818:66-79.

slide-16
SLIDE 16

Upper limb exercise

  • Exercise training in COPD often focuses on lower

limb training (walking, cycling)

Kathiresan et al. J Thorac Dis 2010;2:223-36.

  • 24 studies (n= )
  • Improvements in:

– Endurance capacity (SMD=1.25; 0.16 to 2.66) – Peak exercise capacity (SMD=1.27; 0.59 to 1.94) – Arm muscle strength (SMD=0.46; 0.10 to 0.81)

slide-17
SLIDE 17

Arm exercise - breathlessness (intensity)

During daily activity During exercise

WMD −0.58 (95% CI −1.13 to −0.02) WMD −0.34 (95% CI −0.78 to 0.09)

slide-18
SLIDE 18

Arm exercise – arm fatigue (intensity)

During daily activity During exercise

WMD −0.55 (95% CI −1.08 to −0.01) WMD 0.24 (95% CI −0.33 to 0.81)

slide-19
SLIDE 19

Neuromuscular electrical stimulation

slide-20
SLIDE 20

Jolley & Moxham Eur Resp Rev 2009;818:66-79.

slide-21
SLIDE 21

NMES in advanced disease: exercise

VO2 max during CPET improved in 2 of 3 studies.

Maddocks et al. Cochrane Database of Systematic Reviews 2013;1:CD009419

slide-22
SLIDE 22

NMES and breathlessness

  • Reduced functional impact of breathlessness

– CRQ dyspnoea – Maugeri Resp Failure dyspnea in daily tasks

  • Reduced breathlessness at exercise isotime

– demonstrated in 2 of 3 studies – corresponding increases in exercise endurance – single case of increased inspiratory capacity

Maddocks et al. Cochrane Database of Systematic Reviews 2013;1:CD009419

slide-23
SLIDE 23

Take home messages

  • A strong rationale and

evidence base supports a role for exercise in breathlessness management

  • Exercise is an exemplar for

treating ‘total’ breathlessness

  • not just symptom intensity
slide-24
SLIDE 24

Thank you

matthew.maddocks@kcl.ac.uk @CSI_KCL